CompletedNCT00794040
Citalopram added to methylphenidate for severe irritability in youth
About this title
Read the official source — NCT00794040Medication studyAges 7–17United StatesADHD
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNovember 17, 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 103
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT00794040
- Official title
Show the full official title
A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Add-on citalopram following optimized methylphenidate and Add-on placebo following optimized methylphenidate.
Who was this study for?
Listed age limits: 7 years to 17 years.
